Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Conclusions and Outlook Despite uninspiring outcomes in clinical trials of the first wave of potential NASH therapies, a spate of promising mid-to-late stage clinical trials has provided a needed morale boost to NASH patients, endocrinologists and hepatologists, and caregivers
Samanta S
M., Bernal, A., Capshaw, Z
The product qualifies as a chemical reagent/reference material approved for sale in the EU
US$ 27.21
US$ 27.89
US$ 28.49
US$ 20.64
US$ 21.83
US$ 22.96
US$ 29.44
US$ 27.66
